Literature DB >> 21603517

Chicken sarcoma to human cancers: a lesson in molecular therapeutics.

Om Prakash, Stephen F Bardot, John T Cole.   

Abstract

Entities:  

Keywords:  B-CLL; CML; Lyn; Src

Year:  2007        PMID： 21603517      PMCID： PMC3096390     

Source DB:  PubMed          Journal:  Ochsner J        ISSN： 1524-5012


× No keyword cloud information.
  24 in total

1.  A CD44 survival pathway triggers chemoresistance via lyn kinase and phosphoinositide 3-kinase/Akt in colon carcinoma cells.

Authors:  R C Bates; N S Edwards; G F Burns; D E Fisher
Journal:  Cancer Res       Date:  2001-07-01       Impact factor: 12.701

2.  Lyn kinase activity is the predominant cellular SRC kinase activity in glioblastoma tumor cells.

Authors:  Michelle R Stettner; Wenquan Wang; L Burton Nabors; Suman Bharara; Daniel C Flynn; J Robert Grammer; G Yancey Gillespie; Candece L Gladson
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

3.  RNA-dependent DNA polymerase in virions of RNA tumour viruses.

Authors:  D Baltimore
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

4.  RNA-dependent DNA polymerase in virions of Rous sarcoma virus.

Authors:  H M Temin; S Mizutani
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

5.  Src family tyrosine kinases are activated by Flt3 and are involved in the proliferative effects of leukemia-associated Flt3 mutations.

Authors:  Lisa J Robinson; Jia Xue; Seth J Corey
Journal:  Exp Hematol       Date:  2005-04       Impact factor: 3.084

6.  Dasatinib.

Authors:  Neil P Shah
Journal:  Drugs Today (Barc)       Date:  2007-01       Impact factor: 2.245

7.  v-src induces clonal sarcomas and rapid metastasis following transduction with a replication-defective retrovirus.

Authors:  A W Stoker; M H Sieweke
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

8.  Activating SRC mutation in a subset of advanced human colon cancers.

Authors:  R B Irby; W Mao; D Coppola; J Kang; J M Loubeau; W Trudeau; R Karl; D J Fujita; R Jove; T J Yeatman
Journal:  Nat Genet       Date:  1999-02       Impact factor: 38.330

9.  A Bcr/Abl-independent, Lyn-dependent form of imatinib mesylate (STI-571) resistance is associated with altered expression of Bcl-2.

Authors:  Yun Dai; Mohamed Rahmani; Seth J Corey; Paul Dent; Steven Grant
Journal:  J Biol Chem       Date:  2004-06-02       Impact factor: 5.157

10.  BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571.

Authors:  Nicholas J Donato; Ji Yuan Wu; Jonathan Stapley; Gary Gallick; Hui Lin; Ralph Arlinghaus; Moshe Talpaz
Journal:  Blood       Date:  2003-01-15       Impact factor: 22.113
View more
  1 in total

Review 1.  The promise and challenge of cancer microbiome research.

Authors:  Sumeed Syed Manzoor; Annemiek Doedens; Michael B Burns
Journal:  Genome Biol       Date:  2020-06-02       Impact factor: 13.583
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.